Mouse Anti-MTSS1 (AA 346-445) Recombinant Antibody (CBFYM-0513) (CBMAB-M0641-FY)

Wang, Y., Jia, Z., Liang, C., He, Y., Cong, M., Wu, Q., ... & Hu, G. (2023). MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation. Cell Discovery, 9(1), 20.

Wu, M., Qiu, Q., Zhou, Q., Li, J., Yang, J., Zheng, C., ... & Lu, Y. (2022). circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer. Molecular Cancer, 21(1), 1-19.

Grandits, A. M., Nguyen, C. H., Schlerka, A., Hackl, H., Sill, H., Etzler, J., ... & Wieser, R. (2021). Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness. Leukemia, 35(10), 2827-2839.

Grandits, A. M., & Wieser, R. (2021). Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A. Experimental hematology, 99, 1-11.

Chen, J. X., Wang, Y. P., Zhang, X., Li, G. X., Zheng, K., & Duan, C. Z. (2020). lncRNA Mtss1 promotes inflammatory responses and secondary brain injury after intracerebral hemorrhage by targeting miR-709 in mice. Brain research bulletin, 162, 20-29.

Cong, M., Wang, Y., Yang, Y., Lian, C., Zhuang, X., Li, X., ... & Hu, G. (2020). MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination. Nature Cancer, 1(2), 222-234.

Chen, J., Huang, L., Zhu, Q., Wang, Z., & Tang, Z. (2020). MTSS1 hypermethylation is associated with prostate cancer progression. Journal of cellular physiology, 235(3), 2687-2697.

Hu, Y., Wang, F., Xu, F., Fang, K., Fang, Z., Shuai, X., ... & Zhao, G. (2020). A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. Theranostics, 10(22), 10120.

Liu, K., Jiao, X. D., Hao, J. L., Qin, B. D., Wu, Y., Chen, W., ... & Zang, Y. S. (2019). MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer. OncoTargets and therapy, 12, 5143.

Morley, M. P., Wang, X., Hu, R., Brandimarto, J., Tucker, N. R., Felix, J. F., ... & Cappola, T. P. (2019). Cardioprotective effects of MTSS1 enhancer variants. Circulation, 139(17), 2073-2076.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols